Chronic migraine (cm): prevalence, headache-related disability and sociodemographic factors in the us population: results from the american migraine prevalence and prevention (ampp) study

被引：0
|
作者：
Buse, D. C. [1 ,2 ]
Reed, M. L. [3 ]
Manack, A. N. [4 ]
Fanning, K. [3 ]
Serrano, D. [3 ]
Turkel, C. C. [5 ]
Lipton, R. B. [1 ,2 ]
机构：
[1] Albert Einstein Coll Med, Neurol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Headache, Bronx, NY 10467 USA
[3] Vedanta Res, Hlth Res, Chapel Hill, NC USA
[4] Allergan Pharmaceut Inc, Epidemiol & Populat Hlth, Irvine, CA USA
[5] Allergan Pharmaceut Inc, Res & Dev, Irvine, CA USA
来源：
CEPHALALGIA | 2011年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS1-23
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [41] Acute Treatment Optimization for Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Lipton, R. B.
    Manack, A. N.
    Serrano, D.
    Buse, D. C.
    [J]. HEADACHE, 2012, 52 (05): : 873 - 873
  • [42] Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    Lipton, Richard B.
    Serrano, Daniel
    Nicholson, Robert A.
    Buse, Dawn C.
    Runken, M. Chris
    Reed, Michael L.
    [J]. HEADACHE, 2013, 53 (10): : 1548 - 1563
  • [43] Prevalence of migraine sufferers who are candidates for preventive therapy: Results from the American Migraine Prevalence and Prevention (AMPP) study
    Silberstein, S
    Diamond, S
    Loder, E
    Reed, ML
    Lipton, RB
    [J]. HEADACHE, 2005, 45 (06): : 770 - 771
  • [44] Medical consultation and headache-impact (hit-6) among persons with chronic migraine (cm) and episodic migraine (em): results from the american migraine prevalence and prevention (ampp) study
    Manack, A. N.
    Buse, D. C.
    Serrano, D.
    Varon, S. F.
    Turkel, C. C.
    Lipton, R. B.
    [J]. CEPHALALGIA, 2011, 31 (01) : 29 - 29
  • [45] Asthma is a Risk Factor the for Transformation of Episodic to Chronic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Martin, V. T.
    Buse, D. C.
    Fanning, K.
    Serrano, D.
    Reed, M. L.
    Lipton, R. B.
    [J]. HEADACHE, 2014, 54 : 40 - 41
  • [46] Persistent Frequent Nausea as a Predictor of Progression to Chronic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Reed, M. L.
    Fanning, K. M.
    Serrano, D.
    Buse, D. C.
    Lipton, R. B.
    [J]. CEPHALALGIA, 2013, 33 (S8) : 6 - 6
  • [47] The Relationship of Childhood Maltreatment with Migraine and Tension-Type Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Tietjen, G. E.
    Buse, D. C.
    Fanning, K. M.
    Serrano, D.
    Reed, M. L.
    Lipton, R. B.
    [J]. HEADACHE, 2012, 52 (05): : 910 - 910
  • [48] Factors Associated with Triptan Use in Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention Study (AMPP)
    Chu, M. K.
    Buse, D. C.
    Bigal, M. E.
    Serrano, D.
    Lipton, R. B.
    [J]. HEADACHE, 2010, 50 : S25 - S26
  • [49] The Menopausal Transition Is Associated with Higher Headache Frequencies in Women with Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Martin, V. T.
    Pavlovic, J.
    Fanning, K.
    Buse, D. C.
    Reed, M.
    Derby, C.
    Lipton, R. B.
    Serrano, D.
    [J]. HEADACHE, 2014, 54 : 65 - 66
  • [50] Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Buse, Dawn C.
    Reed, Michael L.
    Fanning, Kristina M.
    Kurth, Tobias
    Lipton, Richard B.
    [J]. HEADACHE, 2017, 57 (01): : 31 - 44
12345